Clinical and Molecular Hepatology

"Ziyan Pan"

Reply to correspondence on “Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease”: Shadi Zerehpoosh, Ziyan Pan, Mohammed Eslam; Clin Mol Hepatol 2026;32(3):e450-e452.
Published online February 5, 2026; DOI: https://doi.org/10.3350/cmh.2026.0133

Letter to the Editor

A call for more efforts to incorporate liver in the metabolic health framework: Letter to the editor on “Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease”: Shadi Zerehpoosh, Ziyan Pan, Mohammed Eslam; Clin Mol Hepatol 2026;32(3):e303-e305.
Published online January 14, 2026; DOI: https://doi.org/10.3350/cmh.2025.1427

Citations

Citations to this article as recorded by

Reply to correspondence on “Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease”
Shadi Zerehpoosh, Ziyan Pan, Mohammed Eslam
Clinical and Molecular Hepatology.2026; 32(3): e450. CrossRef
Correspondence to letter to the editor on “Hypothyroidism and the risk of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease”
Xinrui Jin, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
Clinical and Molecular Hepatology.2026; 32(3): e422. CrossRef